Examining the provisions for research without consent in the emergency setting

Hastings Center Report

Volumn 37, Issue 1, 2007, Pages 12-13

  Sugarman, Jeremy ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33847002312     PISSN: 00930334     EISSN: None     Source Type: Journal    
DOI: 10.1353/hcr.2007.0016     Document Type: Review

References (7)

1. Department of Health and Human Services, Food and Drug Administration, 21 CFR Part 50 (Docket No. 2006D-0331), "Conduct of Emergency Clinical Research," public hearing, Federal Register 71, no. 167 (August 29, 2006): 51143.
2. Food and Drug Administration, Office of Regulatory Affairs, "Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors: Exception from Informed Consent Requirements for Emergency Research," draft released on March 30, 2000.
3. 21 Code of Federal Regulations 50.24.
4. S.F. Goldkind and M. Carome, "Exception from Informed Consent for Emergency Research: Brief Highlights," Part 15 hearing presentation, University System of Maryland, Shady Grove Center, Rockville, Maryland, October 11, 2006.
5. Food and Drug Administration, Office of Regulatory Affairs, "Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors," 14.
6. Ibid., 15.
7. N. Dickert and J. Sugarman, "Ethical Goals of Community Consultation in Research." American Journal of Public Health 95 (2005): 1123-27.